首页>
外国专利>
Screening methods and pharmaceutically active compounds for neurodegenerative diseases
Screening methods and pharmaceutically active compounds for neurodegenerative diseases
展开▼
机译:神经退行性疾病的筛选方法和药物活性化合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention describes methods for detecting compounds that target the auto-inhibitory mechanism of ATP13A2 protein or ATP13A1/3-5 isoforms leading to a modulation of ATPase activity, the method comprising the steps of: providing an assay system comprising ATP13A2 protein or ATP13A1/3-5 isoforms, and a source of ATP, adding a test compound to said assay system, wherein the test compound is not a phosphatidic acid (PA) and/or phosphatidylinositol(3,5)bisphosphate (PI(3,5)P2), determining whether the test compound modifies ATP hydrolysis, compared to a control assay without test compound, wherein a test compound which modifies ATP hydrolysis is identified as modulator of ATPase activity.
展开▼